Inspire Investing LLC Invests $235,000 in Prestige Consumer Healthcare Inc. (NYSE:PBH)

July 10, 2022 Off By administrator

Inspire Investing LLC acquired a new position in Prestige Consumer Healthcare Inc. (NYSE:PBH – Get Rating) during the 1st quarter, HoldingsChannel.com reports. The firm acquired 4,444 shares of the company’s stock, valued at approximately $235,000.

Other hedge funds also recently modified their holdings of the company. EverSource Wealth Advisors LLC acquired a new position in shares of Prestige Consumer Healthcare in the 4th quarter worth approximately $26,000. Rockefeller Capital Management L.P. lifted its holdings in shares of Prestige Consumer Healthcare by 54.4% in the 4th quarter. Rockefeller Capital Management L.P. now owns 843 shares of the company’s stock worth $51,000 after acquiring an additional 297 shares during the last quarter. Point72 Hong Kong Ltd lifted its holdings in shares of Prestige Consumer Healthcare by 1,705.4% in the 4th quarter. Point72 Hong Kong Ltd now owns 1,679 shares of the company’s stock worth $102,000 after acquiring an additional 1,586 shares during the last quarter. Okabena Investment Services Inc. acquired a new position in shares of Prestige Consumer Healthcare in the 4th quarter worth approximately $114,000. Finally, Islay Capital Management LLC acquired a new stake in Prestige Consumer Healthcare during the 4th quarter worth approximately $129,000.

Shares of NYSE:PBH opened at $58.67 on Friday. Prestige Consumer Healthcare Inc. has a 52 week low of $50.95 and a 52 week high of $63.83. The company’s 50 day moving average is $56.32 and its two-hundred day moving average is $56.85. The company has a current ratio of 2.04, a quick ratio of 1.21 and a debt-to-equity ratio of 0.94. The company has a market cap of $2.93 billion, a PE ratio of 14.52, a P/E/G ratio of 1.78 and a beta of 0.51.

Prestige Consumer Healthcare (NYSE:PBH – Get Rating) last announced its quarterly earnings data on Thursday, May 5th. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.89 by $0.02. Prestige Consumer Healthcare had a net margin of 18.90% and a return on equity of 13.82%. The company had revenue of $266.94 million for the quarter, compared to the consensus estimate of $258.25 million. During the same period in the prior year, the firm posted $0.79 EPS. The company’s quarterly revenue was up 12.3% compared to the same quarter last year. As a group, equities research analysts expect that Prestige Consumer Healthcare Inc. will post 4.19 EPS for the current year.

PBH has been the topic of a number of research reports. Jefferies Financial Group upgraded shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating and increased their target price for the stock from $65.00 to $70.00 in a report on Tuesday, May 10th. Oppenheimer upgraded shares of Prestige Consumer Healthcare from a “market perform” rating to an “outperform” rating and set a $63.00 target price on the stock in…

(Excerpt) To read the full article , click here
Image credit: source